Pregled bibliografske jedinice broj: 1269295
Investigating the role of obstructive pulmonary diseases and eosinophil count at admission on all- cause mortality in SARS-CoV-2 patients
Investigating the role of obstructive pulmonary diseases and eosinophil count at admission on all- cause mortality in SARS-CoV-2 patients // Wiener klinische Wochenschrift, (2023), 2023 Apr 24; 1-9 doi:10.1007/s00508-023-02180-w (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1269295 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Investigating the role of obstructive pulmonary
diseases and eosinophil count at admission on all-
cause mortality in SARS-CoV-2 patients
Autori
Salai, Grgur ; Vrazic, Hrvoje ; Kovacevic, Ivona ; Janes, Linda Malnar ; Marasovic, Ivan ; Ranilovic, Darjan ; Vukoja, Damir ; Zelenika Margeta, Marina ; Huljev–Sipos, Ivana ; Lalic, Kristina ; Spoljaric, Marko ; Tekavec-Trkanjec, Jasna ; Vergles, Mirna ; Lucijanic, Marko ; Luksic, Ivica ; Ljubicic, Divo
Izvornik
Wiener klinische Wochenschrift (0043-5325)
(2023), 2023 Apr 24;
1-9
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Asthma ; COVID-19 ; Chronic obstructive pulmonary disease ; Eosinophils ; Retrospective cohort study.
Sažetak
Introduction: The impact of asthma and chronic obstructive pulmonary disease (COPD) in the setting of severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) infection is not clearly defined. Blood eosinophil count is a standard diagnostic test which, according to the previously published literature, might have a potential prognostic role on mortality in patients with SARS-CoV‑2 infection. Aim: To investigate the potential prognostic value of peripheral blood eosinophil count on all-cause mortality of patients hospitalized with SARS-CoV‑2 infection, as well as to assess the impact of asthma or COPD premorbidity on all-cause mortality. Material and methods: We conducted a retrospective registry-based cohort study. Survival analysis was performed by employing the Cox proportional hazards regression model at 30 days of follow-up. Prognostic value of eosinophil count on all-cause mortality was assessed using receiver-operating characteristic (ROC) curve analysis. Results: A total of 5653 participants were included in the study. Our model did not reveal that pre-existing asthma or COPD is a statistically significant covariate for all-cause mortality but, indicated that higher eosinophil count at admission might have a protective effect (hazard ratio, HR 0.13 (95% confidence interval, CI 0.06-0.27), p = 0.0001). ROC curve analysis indicates cut-off value of 20 cells/mm3 (81% specificity ; 30.9% sensitivity). Conclusion: Our results indicate that eosinophil count at hospital admission might have a potential prognostic role for all-cause mortality at 30 days of follow-up ; however this was not demonstrated for pre-existing obstructive lung diseases.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"
Profili:
Hrvoje Vražić
(autor)
Grgur Salai
(autor)
Ivan Marasović
(autor)
Ivica Lukšić
(autor)
Đivo Ljubičić
(autor)
Marko Lucijanic
(autor)
Jasna Tekavec Trkanjec
(autor)
Damir Vukoja
(autor)
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi pubmed.ncbi.nlm.nih.gov link.springer.comCitiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE